US FDA Grants Full Approval to Pfizer COVID-19 Vaccine (Breaking News)
[Asia Economy New York=Correspondent Baek Jong-min] The U.S. Food and Drug Administration (FDA) officially approved the use of the COVID-19 vaccine developed by Pfizer and BioNTech on the 23rd (local time).
Janet Woodcock, Acting FDA Commissioner, stated in a press release, "The Pfizer vaccine has met the FDA's high standards for safety, efficacy, and manufacturing quality." Pfizer submitted its application for full approval of the COVID vaccine to the FDA in early May.
The U.S. authorities are scheduled to hold a press briefing at 11 a.m. on the same day regarding the full approval of the Pfizer vaccine.
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- "Reporters Who First Revealed Jo Jinwoong's Juvenile Offense History Cleared of Juvenile Act Violation"
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
The Pfizer COVID vaccine was used for inoculation after receiving emergency use authorization from the FDA in December last year. U.S. media evaluate that the FDA's full approval provides a basis for companies and schools to decide on vaccine mandates.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.